(Q40341822)

English

Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages

scientific article published on 7 December 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

extracellular matrix

0 references

prostaglandin E2

1 reference

based on heuristic

inferred from title

author name string

Svetlana Pavlovic

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Baoheng Du

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Kazuko Sakamoto

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

K M Faisal Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Chandramohan Natarajan

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Richard M Breyer

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Andrew J Dannenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Domenick J Falcone

8

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

7 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

281

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

3321-3328

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Cyclooxygenase-1 and -2 isoenzymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Cyclooxygenase isozymes and their gene structures and expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Risk of cardiovascular events associated with selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Role of prostacyclin in the cardiovascular response to thromboxane A2

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

National Cancer Institute workshop on chemopreventive properties of nonsteroidal anti-inflammatory drugs: role of COX-dependent and -independent mechanisms

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

EP2 and EP4 prostanoid receptor signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Functional macrophage cell lines transformed by abelson leukemia virus

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostanoid receptors: subtypes and signaling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Differential mRNA expression of prostaglandin receptor subtypes in macrophage activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Involvement of p38 mitogen-activated protein kinase in lipopolysaccharide-induced iNOS and COX-2 expression in J774 macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Design and synthesis of a highly selective EP2-receptor agonist

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Why there are two cyclooxygenase isozymes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostanoids in immunity: Roles revealed by mice deficient in their receptors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Function of prostanoid receptors: studies on knockout mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

The role of protein tyrosine phosphorylation in integrin-mediated gene induction in monocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Integrin-mediated tyrosine phosphorylation and cytokine message induction in monocytic cells. A possible signaling role for the Syk tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Global expression analysis of extracellular matrix-integrin interactions in monocytes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M506846200

21 January 2018

Identifiers

10.1074/JBC.M506846200

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40341822&oldid=1895748198"